🏢
🏢 Company
Definium Therapeutics
Psychedelic medicine biotech company
📊 Rating
2 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Stock Market (1)
- Company Performance (1)
🏷️ Keywords
Definium Therapeutics (1) · stock hits 52-week high (1) · 19.66 USD (1) · market performance (1) · stock price (1) · financial news (1)
📖 Key Information
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
